tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CVM Stock Latest News

CEL-SCI, FDA agree on patient selection approach for Multikine study
The FlyCEL-SCI, FDA agree on patient selection approach for Multikine study
15d ago
CVM
CEL-SCI files to sell 1M shares of common stock for holders
PremiumThe Fly
CEL-SCI files to sell 1M shares of common stock for holders
27d ago
CVM
CEL-SCI announces potential impact on Multikine following FDA ODAC meeting
PremiumThe Fly
CEL-SCI announces potential impact on Multikine following FDA ODAC meeting
1M ago
CVM
CEL-SCI selects Ergomed as CRO for Multikine registration trial
PremiumThe Fly
CEL-SCI selects Ergomed as CRO for Multikine registration trial
2M ago
CVM
CEL-SCI reports new data from Multikine study
PremiumThe Fly
CEL-SCI reports new data from Multikine study
2M ago
CVM
Cel Sci options imply 19.3% move in share price post-earnings
PremiumThe FlyCel Sci options imply 19.3% move in share price post-earnings
3M ago
CVM
3 Penny Stocks to Watch Now, 7/30/24
Premium
Market News
3 Penny Stocks to Watch Now, 7/30/24
4M ago
BFI
CVM
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
CVM
NBY
Cel Sci trading resumes
PremiumThe Fly
Cel Sci trading resumes
4M ago
CVM
CEL-SCI prices ‘best-efforts offering’ of 10.845M shares at $1.00 per share
PremiumThe Fly
CEL-SCI prices ‘best-efforts offering’ of 10.845M shares at $1.00 per share
4M ago
CVM
Cel Sci trading halted, news pending
PremiumThe Fly
Cel Sci trading halted, news pending
4M ago
CVM
CEL-SCI reports results from Multikine bias analysis
PremiumThe Fly
CEL-SCI reports results from Multikine bias analysis
4M ago
CVM
CEL-SCI appoints Robert Watson as chairperson
PremiumThe FlyCEL-SCI appoints Robert Watson as chairperson
5M ago
CVM
CEL-SCI presents Head & Neck Cancer data at IDDST
Premium
The Fly
CEL-SCI presents Head & Neck Cancer data at IDDST
5M ago
CVM
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
AIM
CVM
CEL-SCI gets FDA approval to move forward with Multikine study
PremiumThe Fly
CEL-SCI gets FDA approval to move forward with Multikine study
7M ago
CVM
Cel-Sci Corp Bolsters Board with Finance Expert Mario Gobbo
PremiumCompany Announcements
Cel-Sci Corp Bolsters Board with Finance Expert Mario Gobbo
7M ago
8K
CVM
CEL-SCI: LEAPS vaccine offers ‘new paradigm to treat’ RA published in Frontiers
PremiumThe Fly
CEL-SCI: LEAPS vaccine offers ‘new paradigm to treat’ RA published in Frontiers
8M ago
CVM
CEL-SCI issues letter to shareholders regarding Multikine cancer therapy
PremiumThe Fly
CEL-SCI issues letter to shareholders regarding Multikine cancer therapy
9M ago
CVM
Cel-Sci Corp. Secures Funding for Multikine Development
PremiumCompany AnnouncementsCel-Sci Corp. Secures Funding for Multikine Development
9M ago
8K
CVM
CEL-SCI 3.875M share Secondary priced at $2.00
Premium
The Fly
CEL-SCI 3.875M share Secondary priced at $2.00
10M ago
CVM
CEL-SCI announces Multikine cGMP dedicated facillity commissioning completed
Premium
The Fly
CEL-SCI announces Multikine cGMP dedicated facillity commissioning completed
10M ago
CVM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >